|
Report Date : |
27.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
SURGIPHARM LIMITED |
|
|
|
|
Registered Office : |
Comcraft
House, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
09.04.1985 |
|
|
|
|
Com. Reg. No.: |
C29392 |
|
|
|
|
Legal Form : |
Limited Corporation |
|
|
|
|
Line of Business : |
Registered to operate
importers and dealers in all types of pharmaceutical, surgical goods, creams
and hospital requirements |
|
|
|
|
No. of Employees : |
350 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Source
: CIA |
|
Registered Name: |
SURGIPHARM
LIMITED |
|
Requested Name: |
SURGIPHARM LIMITED |
|
Other Names: |
None |
|
Physical Address: |
|
|
Registered Address: |
Comcraft
House, |
|
Postal Address: |
|
|
|
|
|
Country: |
|
|
Phone: |
254-20-224228/3749304/6/12 |
|
Cell |
254-722-204707/734224228 |
|
Fax: |
254-20-215054 |
|
Email: |
sales@surgipharm.com |
|
Website: |
www.surgipharm.com |
|
Financial Index as of
December 2013 shows subject firm with a medium risk of credit. However, bank
and credit information obtained reveal a history of prompt payments. |
|
Legal Form: |
Limited Corporation |
|
|
Date Incorporated: |
09-April-1985 |
|
|
Reg. Number: |
C29392 |
|
|
Nominal Capital |
KES.
1,000,000,000 being Shares 10,000,000 each Value KES. 100 |
|
|
Subscribed Capital |
KES.
100,000,000 being 1,000,000 |
|
|
Subscribed Capital is Subscribed in the following form: |
||
|
|
Position |
Shares |
|
Dr. Vijay Kanwle Majni |
MD |
600,000 |
|
Mr. Vipinchandra Dhirajlal Shah |
Director |
375,000 |
|
Mr.
Rakesh
Vinavak |
Director |
25,000 |
|
Mr. Rajesh Maini |
Director |
|
|
None |
Parent company. |
|
None |
Subsidiary company. |
|
SURGIPHARM ( |
Affiliated company. |
|
None |
Shareholder of subject
firm. |
|
|
Branches of the firm |
|
Registered to operate
importers and dealers in all types of pharmaceutical, surgical goods, creams
and hospital requirements |
|
|
Imports: |
Asia, Europe, |
|
Exports: |
Neighboring countries |
|
Trademarks: |
None |
|
Terms of sale: |
Cash (40%) and 30 days (60%), invoices. |
|
|
|
|
Main Customers: |
hospitals, chemists, distributors, laboratories etc |
|
Employees: |
350 employees. |
|
Vehicles: |
Several motor vehicles. |
|
Territory of sales: |
|
|
Location: |
Owned premises, 20.000 square feet, |
|
Auditors: |
SHIRISH SHAH AND COMPANY |
|
Insurance Brokers: |
Information not
available. |
|
Currency Reported: |
|
|
Approx. Ex. Rate: |
1 US Dollar = 89.30 |
|
Fiscal Year End: |
December 31, 2013 |
|
Inflation: |
According to information given by independent sources, the inflation
at December 31st, 2013 was of 13%. |
|
|
|
|
Financial Information
Submitted below |
|
|
Bank Name: |
BARCLAYS
BANK |
|
Branch: |
|
|
Comments: |
Other Banks |
|
|
CITIBANK
N.A, |
|
|
|
|
TRADE REFERENCES |
|
|
Experiences: |
Good |
|
|
|
|
|
|
|
NOTARIAL BONDS |
None |
|
This information was
obtained from outside sources other than the subject company itself and
confirmed the above subject. Subject underwent a
capital increase andshare ownership changes. |



FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.57 |
|
|
1 |
Rs.100.42 |
|
Euro |
1 |
Rs.78.44 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.